A layered composite for scar treatment and prevention, the layered composite including a backing section; a drug matrix section; and a skin-interfacing section. The drug matrix section may be disposed between the back section and the skin-interfacing section. The drug matrix section may include pirfenidone in an amount of from about 1 to about 20 mg/cm.sup.2. The layered composite may provide greater than about 75% release of the pirfenidone over a period of about 48 to 72 hours. A method for scar treatment and prevention that includes applying a layered composite as described to a burn wound.

A medical dressing having a geometrical plane of symmetry. A border portion extends along the contour of the pad. A central portion of the dressing has a smaller width perpendicular to the plane of symmetry than the widths of the adjoining portions. The medical dressing comprises a gripping tab which is coplanar with the border portion and which projects outwardly from the border portion. The medical dressing may be used for pressure ulcer prevention, such as at a heel of a human body.

A dressing interface for connecting a negative-pressure source to a dressing may have a coupling member comprising an aperture, a first adhesive region having a first region peel strength, and a second adhesive region having a second region peel strength less than the first region peel strength. The dressing interface may further have a flange coupled to the coupling member, and a conduit housing coupled to the flange and extending through the aperture in the contact layer.

The present disclosure relates generally to wound dressings and reduced-pressure wound dressing apparatuses that detect the presence of proteases in a wound upon application. The wound dressings and the reduced-pressure wound dressing apparatus of the present technology can be a visual indicator of the presence of proteases in a wound; and a visual indicator of the wounds healing status.

The present invention generally relates to dressings such as bandages or tapes having improved extensibility and conformability to human skin and joints.

The present invention generally relates to dressings such as bandages or tapes having improved extensibility and conformability to human skin and joints.

A wound dressing comprising: a backing sheet; a layer of pressure-sensitive adhesive on the backing sheet; an island of absorbent material having smaller area than the backing sheet and applied onto a central region of the backing sheet so as to leave a margin of adhesive-coated backing sheet around the absorbent material, and an apertured wound facing layer applied over the absorbent material and adhered to the backing sheet around said island by said pressure-sensitive adhesive, wherein the apertured wound facing layer comprises an apertured substrate having a coating of a silicone gel on the wound facing surface thereof, the open area of the apertured wound facing layer is from about 5% to about 75%, and the apertured wound facing layer comprises apertures having an open area of from about 2 mm2 to about 100 mm.sup.2.

A treatment system including one or more of a wound dressing having one or more of a substrate element, a dressing member disposed on the substrate element, an adhesive element disposed on the substrate element, and a tether connecting the wound dressing to a treatment device.

An improved adhesive bandage is disclosed. The adhesive bandage includes a rectangular portion of backing sheet material defining a forward and a rear side, pressure-sensitive adhesive on the forward side, separated by a rectangular portion of dressing material attached to a central area, and two rectangular portions of release paper each removably attached to either the forward or rear side of the adhesive bandage. The adhesive bandage also includes four tabs for the removal of the release paper, placed at the midpoints on either side of the adhesive bandage.

This invention pertains to polyester compositions. More particularly, this invention pertains to polyester compositions that have particular utility as component of medical adhesive tapes, topical and transdermal drug delivery patches and cosmetic patches. The polyester is comprised of a diacid selected from the group consisting of a cyclohexane dicarboxylic acid, a dimethylcyclohexane dicarboxylic acid, and combinations thereof and polytetramethylene ether glycol and optionally a branching agent.